Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance
Moreover, the overall therapeutic burden on patients must be carefully considered when integrating neuroprotective strategies into current glaucoma management protocols
Zhikai Chi, assistant professor of pathology at UT Southwestern
3 In the REIMAGINE 1 trial, the most commonly reported adverse events (AEs) were gastrointestinal (GI)-related, occurring in 33/62 (53%) participants in the CagriSema 2.4 mg/2.4 mg group, 28/63 (44%) participants in the CagriSema 1 mg/1 mg group, and 13/64 (20%) participants in the placebo group
It is also essential to avoid or minimize exposure to toxins, pollutants, and stressors that may deplete Glutathione levels